Delivery Order SPE2DB24D1034-SPE2DB25FWFP4
- Not listed
- The Defense Logistics Agency awarded a $318,360 delivery order to Amerisourcebergen Drug Corporation for the supply of Furosemide 20 mg/2 ml vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued this firm fixed price order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver the specified medication to a facility in Conshohocken, Pennsylvania by the end date of August 28, 2023. No subcontractors or set...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Furosemide 40 mg/4 ml vials. The contract, which does not have a set-aside designation, has a ceiling value of $1,679.04 and an ultimate completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government...
- The Defense Logistics Agency awarded a $41,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562319929, described as Furosemide 40 mg/4 ml vials. The single day contract runs from September 27 through 28, 2023 for product delivery to a location in Conshohocken, Pennsylvania. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order from its corporate offices to support the Defense Logistics Agency's stocking of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $109.70 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561577977 units of the pharmaceutical product Furosemide 100 mg/10 ml vial, with each vial containing 10 ml of solution. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 24, 2023 through July 25, 2023. No major subcontractors or...
- The Defense Logistics Agency Troop Support Medical awarded a $637.44 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of furosemide. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA Troop Support and other Department of Defense customers. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 28 and July...
- The Defense Logistics Agency Troop Support Medical awarded a $164,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 25,000 units of the generic pharmaceutical furosemide. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply various medical products to DLA customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with all items to be delivered by August 15, 2023. No...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of SYFOVRE 15 mg/0.1 mL vials. The contract, valued at $2,947.44, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. This award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, issued without set-aside designation, represents a competitively awarded contract to supply pharmaceutical and medical products to support federal military and veteran healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFP4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Furosemide 100 mg/10 mL vials with a ceiling value of $1,042.59 and an ultimate completion date of September 10, 2025. This competitive award, which utilized no set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order exemplifies AmerisourceBergen's critical role as a prime pharmaceutical vendor supporting the Defense Health Agency, U.S. Coast Guard, and broader military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries through the DLA Medical Supply Chain, supplying generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's IDC serves as a comprehensive global pharmaceutical support vehicle enabling flexible fulfillment of federal medical supply requirements across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/9/25 |